Controlled substances are critical medications vital for treating diverse medical conditions, including opioids and stimulants. Despite their indispensable role, these compounds often present formulation challenges like low solubility and poor bioavailability. Munit’s advanced micronization technology precisely reduces particle sizes, significantly enhancing solubility and absorption.

Our state-of-the-art process uniformly micronizes drug particles to desired dimensions, rigorously maintaining intrinsic quality and stability. This results in superior solubility, faster absorption, and reduced potential side effects, fostering better patient compliance and treatment outcomes. Our expert scientists meticulously evaluate Particle Size Distribution (PSD) using advanced analytical tools, ensuring high-quality micronized controlled substances meet all regulatory and performance requirements.

Munit ensures full compliance with cGMP regulations and offers customised solutions for unique development challenges.